Protagonist Therapeutics Inc buy BTIG Research
Start price
28.10.25
/
50%
€66.00
Target price
28.10.26
€70.34
Performance (%)
1.52%
Price
29.01.26
€67.00
Summary
This prediction is currently active. With a performance of 1.52%, the BUY prediction by BTIG_Research for Protagonist Therapeutics Inc is trending in the right direction. This prediction currently runs until 28.10.26. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Protagonist Therapeutics Inc | -6.944% | -6.944% |
| iShares Core DAX® | -1.410% | 0.471% |
| iShares Nasdaq 100 | -0.450% | -0.305% |
| iShares Nikkei 225® | -0.224% | 5.529% |
| iShares S&P 500 | -1.095% | -0.774% |
Comments by BTIG_Research for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics (NASDAQ:PTGX) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $82.00 price target on the stock.
Ratings data for PTGX provided by MarketBeat
Stopped prediction by BTIG_Research for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€50.50
24.07.24
24.07.24
€46.93
24.07.25
24.07.25
-4.16%
25.07.25
25.07.25
